ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Tiglutik Oral Suspension
americanpharmaceuticalreview
September 07, 2018ITF Pharma announced the U.S. Food and Drug Administration (FDA) has approved Tiglutik (riluzole) oral suspension for the treatment of amyotrophic lateral sclerosis (ALS).
Pharma Sources Insight January 2025
